FLAME Trial

About Inari Medical

Inari Medical is a publicly traded leader in mechanical thrombectomy for venous diseases, with a commercial portfolio targeting pulmonary embolism, deep vein thrombosis, and in-stent thrombosis. The company has established a significant market presence, having treated over 100,000 patients, and is supported by a robust clinical research program aimed at generating evidence to drive adoption. Its business model focuses on direct commercialization of its proprietary devices in the U.S. and key international markets, supported by extensive physician education and reimbursement resources.

Therapeutic Areas

Other Not Specified Drugs